Clinical Trial Update: A Randomized, Double-Blind, Placebo-Controlled Study With an Open-Label, Long-Term Safety Phase to Evaluate the Efficacy and Safety of TV-44749 in Adults With Schizophrenia [Phase 3]

View source ↗

Summary

Phase 3 study of TV-44749 in adults with schizophrenia completed, with results posted. The trial used a randomized, double-blind, placebo-controlled design and …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• TV-44749

Snippet

Sponsor: Teva Branded Pharmaceutical Products R&D LLC | Conditions: Schizophrenia | Phase 3 | Status: COMPLETED | Results posted: 2026-01-09